SLE and antiphospholipid syndrome [240–264]
Identifieur interne : 001F56 ( Main/Exploration ); précédent : 001F55; suivant : 001F57SLE and antiphospholipid syndrome [240–264]
Auteurs :Source :
- Rheumatology [ 1462-0324 ] ; 2004.
English descriptors
- Teeft :
- Abdominal angina, Abnormal, Abnormal abis, Abnormal abpi, Abpi, Academic department, Academic unit, Adverse events, American college, Antibody, Anticardiolipin antibodies, Antiphospholipid, Antiphospholipid antibodies, Antiphospholipid syndrome, Antiphospholipid syndrome thursday, Antithyroid antibodies, April, Arginine, Arginine residues, Autoimmune phenotype, Autoimmunity, Baseline, Biology unit, Blood pressure, Blood tests, Bxsb strain, Cardiac, Cardiac lupus, Cardiovascular, Cardiovascular disease, Cardiovascular risk, Cardiovascular risk factors, Carotid arteries, Caucasian, Cell supernatants, Centre, Chain combinations, Chase farm hospital, Chest infection, Chest pain, Child health, Chromosome, Chronic headache, Clinical evidence, Clinical immunology, Clinical utility, Coeliac, Coeliac artery stenosis, Cohort, Common problem, Complementary therapies, Complete occlusion, Confocal microscopy, Congenic mice, Congenic strain, Connective tissue disease, Consecutive patients, Consensus statement, Control group, Control subjects, Daily questionnaire, Diabetes mellitus, Disease activity, Disease duration, Disease susceptibility, Dsdna, Elisa, Environmental quality, Eric bywaters centre, Erythematosus, Ethnic origin, Family history, Fasting, Fasting insulin levels, Fasting lipids, Haplotype, Hazard ratio, Healthy control subjects, Healthy controls, Healthy controls subjects, Healthy subjects, High prevalence, High sensitivity, Higher frequency, Hormone replacement therapy, Hughes syndrome, Human antibody, Hyper responsiveness, Hypertension, Hypertensive, Immunology, Immunology department, Imperial college, Important role, India institute, Intima media thickness, Ischaemic heart disease, Italy background, Khamashta, Kingdom background, Laboratory data, Laboratory factors, Leeds, Light chains, Lipid, Lipid rafts, Livedo, Livedo reticularis, Lmwh, Lmwh treatment, Locus, Lupus, Lupus anticoagulant, Lupus patients, Lupus research unit, Magnetic resonance angiography, Median, Median disease duration, Medical records, Medical sciences, Molecular weight heparin, Monoclonal antibodies, Morbidity, Musculoskeletal disease, Mutation, Normal range, Northwick park hospital, Oral prednisolone treatment, Pap, Paps group, Paps patients, Pilot study, Polyarteritis nodosa, Positive patients, Possible associations, Poster session, Prednisolone, Prednisolone treatment, Pregnancy morbidity, Prevalence, Primary antiphospholipid syndrome, Primary antiphospholipid syndrome baron, Primary syndrome, Prospective study, Psychological quality, Randomised trial, Range years, Rayne, Rayne institute, Renal, Renal artery stenosis, Renal disease, Renal impairment, Renal involvement, Reticularis, Rheumatic diseases, Rheumatology, Rheumatology section, Risk factors, Sapporo criteria, Serine mutation, Single mutation, Spontaneous autoimmunity, Spontaneous proliferation, Stable expression system, Stenosis, Steroid, Strict protocol, Syndrome, Systemic, Systemic lupus erythematosus, Systemic vasculitides, Tertiary referral centre, Thrombosis, Thrombotic microangiopathy, Total cholesterol, Transient expression system, Treatment period, Troublesome symptoms, University college london, Vasculitis, Wide variety.
Url:
DOI: 10.1093/oxfordjournals.rheumatology.a005773
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002705
- to stream Istex, to step Curation: 002705
- to stream Istex, to step Checkpoint: 000D97
- to stream Main, to step Merge: 001F71
- to stream Main, to step Curation: 001F56
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">SLE and antiphospholipid syndrome [240–264]</title>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:CD8E7F0B58A269299F02CBF9D74AA201C547C685</idno>
<date when="2004" year="2004">2004</date>
<idno type="doi">10.1093/oxfordjournals.rheumatology.a005773</idno>
<idno type="url">https://api.istex.fr/ark:/67375/HXZ-82LNLBNL-Q/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002705</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002705</idno>
<idno type="wicri:Area/Istex/Curation">002705</idno>
<idno type="wicri:Area/Istex/Checkpoint">000D97</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000D97</idno>
<idno type="wicri:Area/Main/Merge">001F71</idno>
<idno type="wicri:Area/Main/Curation">001F56</idno>
<idno type="wicri:Area/Main/Exploration">001F56</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">SLE and antiphospholipid syndrome [240–264]</title>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Rheumatology</title>
<title level="j" type="issue">British Society for Rheumatology Annual Meeting 20–23 April 2004 Edinburgh, Scotland and British Health Professionals Spring Meeting 21–23 April 2004 Edinburgh, Scotland</title>
<title level="j" type="abbrev">Rheumatology</title>
<idno type="ISSN">1462-0324</idno>
<idno type="eISSN">1462-0332</idno>
<imprint><publisher>Oxford University Press</publisher>
<date when="2004-04">2004</date>
<biblScope unit="vol">43</biblScope>
<biblScope unit="issue">suppl_2</biblScope>
<biblScope unit="page" from="ii103">ii103</biblScope>
<biblScope unit="page" to="ii110">ii110</biblScope>
</imprint>
<idno type="ISSN">1462-0324</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1462-0324</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Abdominal angina</term>
<term>Abnormal</term>
<term>Abnormal abis</term>
<term>Abnormal abpi</term>
<term>Abpi</term>
<term>Academic department</term>
<term>Academic unit</term>
<term>Adverse events</term>
<term>American college</term>
<term>Antibody</term>
<term>Anticardiolipin antibodies</term>
<term>Antiphospholipid</term>
<term>Antiphospholipid antibodies</term>
<term>Antiphospholipid syndrome</term>
<term>Antiphospholipid syndrome thursday</term>
<term>Antithyroid antibodies</term>
<term>April</term>
<term>Arginine</term>
<term>Arginine residues</term>
<term>Autoimmune phenotype</term>
<term>Autoimmunity</term>
<term>Baseline</term>
<term>Biology unit</term>
<term>Blood pressure</term>
<term>Blood tests</term>
<term>Bxsb strain</term>
<term>Cardiac</term>
<term>Cardiac lupus</term>
<term>Cardiovascular</term>
<term>Cardiovascular disease</term>
<term>Cardiovascular risk</term>
<term>Cardiovascular risk factors</term>
<term>Carotid arteries</term>
<term>Caucasian</term>
<term>Cell supernatants</term>
<term>Centre</term>
<term>Chain combinations</term>
<term>Chase farm hospital</term>
<term>Chest infection</term>
<term>Chest pain</term>
<term>Child health</term>
<term>Chromosome</term>
<term>Chronic headache</term>
<term>Clinical evidence</term>
<term>Clinical immunology</term>
<term>Clinical utility</term>
<term>Coeliac</term>
<term>Coeliac artery stenosis</term>
<term>Cohort</term>
<term>Common problem</term>
<term>Complementary therapies</term>
<term>Complete occlusion</term>
<term>Confocal microscopy</term>
<term>Congenic mice</term>
<term>Congenic strain</term>
<term>Connective tissue disease</term>
<term>Consecutive patients</term>
<term>Consensus statement</term>
<term>Control group</term>
<term>Control subjects</term>
<term>Daily questionnaire</term>
<term>Diabetes mellitus</term>
<term>Disease activity</term>
<term>Disease duration</term>
<term>Disease susceptibility</term>
<term>Dsdna</term>
<term>Elisa</term>
<term>Environmental quality</term>
<term>Eric bywaters centre</term>
<term>Erythematosus</term>
<term>Ethnic origin</term>
<term>Family history</term>
<term>Fasting</term>
<term>Fasting insulin levels</term>
<term>Fasting lipids</term>
<term>Haplotype</term>
<term>Hazard ratio</term>
<term>Healthy control subjects</term>
<term>Healthy controls</term>
<term>Healthy controls subjects</term>
<term>Healthy subjects</term>
<term>High prevalence</term>
<term>High sensitivity</term>
<term>Higher frequency</term>
<term>Hormone replacement therapy</term>
<term>Hughes syndrome</term>
<term>Human antibody</term>
<term>Hyper responsiveness</term>
<term>Hypertension</term>
<term>Hypertensive</term>
<term>Immunology</term>
<term>Immunology department</term>
<term>Imperial college</term>
<term>Important role</term>
<term>India institute</term>
<term>Intima media thickness</term>
<term>Ischaemic heart disease</term>
<term>Italy background</term>
<term>Khamashta</term>
<term>Kingdom background</term>
<term>Laboratory data</term>
<term>Laboratory factors</term>
<term>Leeds</term>
<term>Light chains</term>
<term>Lipid</term>
<term>Lipid rafts</term>
<term>Livedo</term>
<term>Livedo reticularis</term>
<term>Lmwh</term>
<term>Lmwh treatment</term>
<term>Locus</term>
<term>Lupus</term>
<term>Lupus anticoagulant</term>
<term>Lupus patients</term>
<term>Lupus research unit</term>
<term>Magnetic resonance angiography</term>
<term>Median</term>
<term>Median disease duration</term>
<term>Medical records</term>
<term>Medical sciences</term>
<term>Molecular weight heparin</term>
<term>Monoclonal antibodies</term>
<term>Morbidity</term>
<term>Musculoskeletal disease</term>
<term>Mutation</term>
<term>Normal range</term>
<term>Northwick park hospital</term>
<term>Oral prednisolone treatment</term>
<term>Pap</term>
<term>Paps group</term>
<term>Paps patients</term>
<term>Pilot study</term>
<term>Polyarteritis nodosa</term>
<term>Positive patients</term>
<term>Possible associations</term>
<term>Poster session</term>
<term>Prednisolone</term>
<term>Prednisolone treatment</term>
<term>Pregnancy morbidity</term>
<term>Prevalence</term>
<term>Primary antiphospholipid syndrome</term>
<term>Primary antiphospholipid syndrome baron</term>
<term>Primary syndrome</term>
<term>Prospective study</term>
<term>Psychological quality</term>
<term>Randomised trial</term>
<term>Range years</term>
<term>Rayne</term>
<term>Rayne institute</term>
<term>Renal</term>
<term>Renal artery stenosis</term>
<term>Renal disease</term>
<term>Renal impairment</term>
<term>Renal involvement</term>
<term>Reticularis</term>
<term>Rheumatic diseases</term>
<term>Rheumatology</term>
<term>Rheumatology section</term>
<term>Risk factors</term>
<term>Sapporo criteria</term>
<term>Serine mutation</term>
<term>Single mutation</term>
<term>Spontaneous autoimmunity</term>
<term>Spontaneous proliferation</term>
<term>Stable expression system</term>
<term>Stenosis</term>
<term>Steroid</term>
<term>Strict protocol</term>
<term>Syndrome</term>
<term>Systemic</term>
<term>Systemic lupus erythematosus</term>
<term>Systemic vasculitides</term>
<term>Tertiary referral centre</term>
<term>Thrombosis</term>
<term>Thrombotic microangiopathy</term>
<term>Total cholesterol</term>
<term>Transient expression system</term>
<term>Treatment period</term>
<term>Troublesome symptoms</term>
<term>University college london</term>
<term>Vasculitis</term>
<term>Wide variety</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list></list>
<tree></tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F56 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001F56 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:CD8E7F0B58A269299F02CBF9D74AA201C547C685 |texte= SLE and antiphospholipid syndrome [240–264] }}
This area was generated with Dilib version V0.6.33. |